BNP Paribas Financial Markets’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
Other funds holding THRD
CF
MIM
JC
AB
GI
N
BNP Paribas Financial Markets's THRD Position: Q3 2025 in Review
BNP Paribas Financial Markets sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 73,526 shares — an estimated $399K sold.
BNP Paribas Financial Markets first reported a position in THRD in Q4 2024 and held it in 3 quarters. The position peaked at $399K in Q2 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.
- BNP Paribas Financial Markets reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 73,526 Third Harmonic Bio shares in Q3 2025, an estimated $399K.
- BNP Paribas Financial Markets first reported a position in Third Harmonic Bio in Q4 2024 and held it in 3 quarters.
- BNP Paribas Financial Markets's Third Harmonic Bio position peaked at $399K in Q2 2025.
- 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.